新光药业：和丰投资累计减持0.7743%股份

Group 1 - The core point of the article is that Shengzhou Hefeng Investment Co., Ltd., a shareholder holding more than 5% of Xinguang Pharmaceutical, has reduced its shareholding by 1,238,900 shares, representing 0.7743% of the company's total share capital [1] - Before the reduction, Hefeng Investment held 26,780,900 shares, which accounted for 16.7381% of the total share capital [1] - After the reduction, Hefeng Investment now holds 25,542,000 shares, which is 15.9638% of the total share capital, indicating a change that touches the 1% integer threshold [1]